APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood & Tissue Kit

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Blood & Tissue Kit Industry Growth and Trends Forecast to 2032

29 December 2025119 pages

Choose your research edition.

Industry ResearchBlood & Tissue Kit Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood & Tissue Kit Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Blood & Tissue Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood & Tissue Kit Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood & Tissue Kit Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Blood & Tissue Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood & Tissue Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood & Tissue Kit include QIAGEN, Analytik Jena, Axygen (Corning), Bio-Rad, BioVision, Geneaid, Illumina, Lucigen (Biosearch Technologies) and Macherey-Nagel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Blood & Tissue Kit market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Blood & Tissue Kit market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blood & Tissue Kit market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blood & Tissue Kit.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Blood & Tissue Kit market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Blood & Tissue Kit Market by Company

QIAGEN

Analytik Jena

Axygen (Corning)

Bio-Rad

BioVision

Geneaid

Illumina

Lucigen (Biosearch Technologies)

Macherey-Nagel

Norgen

Omega Bio-tek

Promega

Sigma-Aldrich (Merck)

Zymo Research

MGI Tech Co., Ltd.

Roche

Thermo Fisher Scientific

Blood & Tissue Kit Segment by Type

Buffy Coat

Whole Blood

Plasma or Serum

Blood & Tissue Kit Segment by Application

R&D Organisations

Biotechnology Companies

Blood & Tissue Kit Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood & Tissue Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood & Tissue Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood & Tissue Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood & Tissue Kit manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Blood & Tissue Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Buffy Coat Table 2. Major Company of Whole Blood Table 3. Major Company of Plasma or Serum Table 4. Global Blood & Tissue Kit Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Blood & Tissue Kit Sales by Type (2021-2026) & (K Units) Table 6. Global Blood & Tissue Kit Sales Market Share in Volume by Type (2021-2026) Table 7. Global Blood & Tissue Kit Sales by Type (2021-2026) & (US$ Million) Table 8. Global Blood & Tissue Kit Sales Market Share in Value by Type (2021-2026) Table 9. Global Blood & Tissue Kit Price by Type (2021-2026) & (US$/Unit) Table 10. Global Blood & Tissue Kit Sales by Type (2027-2032) & (K Units) Table 11. Global Blood & Tissue Kit Sales Market Share in Volume by Type (2027-2032) Table 12. Global Blood & Tissue Kit Sales by Type (2027-2032) & (US$ Million) Table 13. Global Blood & Tissue Kit Sales Market Share in Value by Type (2027-2032) Table 14. Global Blood & Tissue Kit Price by Type (2027-2032) & (US$/Unit) Table 15. North America Blood & Tissue Kit Sales by Type (2021-2026) & (K Units) Table 16. North America Blood & Tissue Kit Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Blood & Tissue Kit Sales by Type (2021-2026) & (K Units) Table 18. Europe Blood & Tissue Kit Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Blood & Tissue Kit Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Blood & Tissue Kit Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Blood & Tissue Kit Sales by Type (2021-2026) & (K Units) Table 22. Latin America Blood & Tissue Kit Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Blood & Tissue Kit Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Blood & Tissue Kit Sales by Type (2021-2026) & (US$ Million) Table 25. Blood & Tissue Kit Industry Trends Table 26. Blood & Tissue Kit Industry Drivers Table 27. Blood & Tissue Kit Industry Opportunities and Challenges Table 28. Blood & Tissue Kit Industry Restraints Table 29. Global Blood & Tissue Kit Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Blood & Tissue Kit Revenue Market Share by Company (2021-2026) Table 31. Global Blood & Tissue Kit Sales by Company (2021-2026) & (K Units) Table 32. Global Blood & Tissue Kit Sales Share by Company (2021-2026) Table 33. Global Blood & Tissue Kit Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Blood & Tissue Kit Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Blood & Tissue Kit Major Company Production Sites and Headquarters Table 36. Global Blood & Tissue Kit Company, Product Type & Application Table 37. Global Blood & Tissue Kit Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Blood & Tissue Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Blood & Tissue Kit Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Blood & Tissue Kit Sales by Region (2021-2026) & (K Units) Table 42. Global Blood & Tissue Kit Sales Market Share in Volume by Region (2021-2026) Table 43. Global Blood & Tissue Kit Sales by Region (2021-2026) & (US$ Million) Table 44. Global Blood & Tissue Kit Sales Market Share in Value by Region (2021-2026) Table 45. Global Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Blood & Tissue Kit Sales by Region (2027-2032) & (K Units) Table 47. Global Blood & Tissue Kit Sales Market Share in Volume by Region (2027-2032) Table 48. Global Blood & Tissue Kit Sales by Region (2027-2032) & (US$ Million) Table 49. Global Blood & Tissue Kit Sales Market Share in Value by Region (2027-2032) Table 50. Global Blood & Tissue Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Blood & Tissue Kit Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Blood & Tissue Kit Sales by Application (2021-2026) & (K Units) Table 53. Global Blood & Tissue Kit Sales Market Share in Volume by Application (2021-2026) Table 54. Global Blood & Tissue Kit Sales by Application (2021-2026) & (US$ Million) Table 55. Global Blood & Tissue Kit Sales Market Share in Value by Application (2021-2026) Table 56. Global Blood & Tissue Kit Price by Application (2021-2026) & (US$/Unit) Table 57. Global Blood & Tissue Kit Sales by Application (2027-2032) & (K Units) Table 58. Global Blood & Tissue Kit Sales Market Share in Volume by Application (2027-2032) Table 59. Global Blood & Tissue Kit Sales by Application (2027-2032) & (US$ Million) Table 60. Global Blood & Tissue Kit Sales Market Share in Value by Application (2027-2032) Table 61. Global Blood & Tissue Kit Price by Application (2027-2032) & (US$/Unit) Table 62. North America Blood & Tissue Kit Sales by Application (2021-2026) & (K Units) Table 63. North America Blood & Tissue Kit Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Blood & Tissue Kit Sales by Application (2021-2026) & (K Units) Table 65. Europe Blood & Tissue Kit Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Blood & Tissue Kit Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Blood & Tissue Kit Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Blood & Tissue Kit Sales by Application (2021-2026) & (K Units) Table 69. Latin America Blood & Tissue Kit Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Blood & Tissue Kit Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Blood & Tissue Kit Sales by Application (2021-2026) & (US$ Million) Table 72. QIAGEN Company Information Table 73. QIAGEN Business Overview Table 74. QIAGEN Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. QIAGEN Blood & Tissue Kit Product Portfolio Table 76. QIAGEN Recent Development Table 77. Analytik Jena Company Information Table 78. Analytik Jena Business Overview Table 79. Analytik Jena Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Analytik Jena Blood & Tissue Kit Product Portfolio Table 81. Analytik Jena Recent Development Table 82. Axygen (Corning) Company Information Table 83. Axygen (Corning) Business Overview Table 84. Axygen (Corning) Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Axygen (Corning) Blood & Tissue Kit Product Portfolio Table 86. Axygen (Corning) Recent Development Table 87. Bio-Rad Company Information Table 88. Bio-Rad Business Overview Table 89. Bio-Rad Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bio-Rad Blood & Tissue Kit Product Portfolio Table 91. Bio-Rad Recent Development Table 92. BioVision Company Information Table 93. BioVision Business Overview Table 94. BioVision Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. BioVision Blood & Tissue Kit Product Portfolio Table 96. BioVision Recent Development Table 97. Geneaid Company Information Table 98. Geneaid Business Overview Table 99. Geneaid Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Geneaid Blood & Tissue Kit Product Portfolio Table 101. Geneaid Recent Development Table 102. Illumina Company Information Table 103. Illumina Business Overview Table 104. Illumina Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Illumina Blood & Tissue Kit Product Portfolio Table 106. Illumina Recent Development Table 107. Lucigen (Biosearch Technologies) Company Information Table 108. Lucigen (Biosearch Technologies) Business Overview Table 109. Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio Table 111. Lucigen (Biosearch Technologies) Recent Development Table 112. Macherey-Nagel Company Information Table 113. Macherey-Nagel Business Overview Table 114. Macherey-Nagel Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Macherey-Nagel Blood & Tissue Kit Product Portfolio Table 116. Macherey-Nagel Recent Development Table 117. Norgen Company Information Table 118. Norgen Business Overview Table 119. Norgen Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Norgen Blood & Tissue Kit Product Portfolio Table 121. Norgen Recent Development Table 122. Omega Bio-tek Company Information Table 123. Omega Bio-tek Business Overview Table 124. Omega Bio-tek Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Omega Bio-tek Blood & Tissue Kit Product Portfolio Table 126. Omega Bio-tek Recent Development Table 127. Promega Company Information Table 128. Promega Business Overview Table 129. Promega Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Promega Blood & Tissue Kit Product Portfolio Table 131. Promega Recent Development Table 132. Sigma-Aldrich (Merck) Company Information Table 133. Sigma-Aldrich (Merck) Business Overview Table 134. Sigma-Aldrich (Merck) Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio Table 136. Sigma-Aldrich (Merck) Recent Development Table 137. Zymo Research Company Information Table 138. Zymo Research Business Overview Table 139. Zymo Research Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Zymo Research Blood & Tissue Kit Product Portfolio Table 141. Zymo Research Recent Development Table 142. MGI Tech Co., Ltd. Company Information Table 143. MGI Tech Co., Ltd. Business Overview Table 144. MGI Tech Co., Ltd. Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio Table 146. MGI Tech Co., Ltd. Recent Development Table 147. Roche Company Information Table 148. Roche Business Overview Table 149. Roche Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Roche Blood & Tissue Kit Product Portfolio Table 151. Roche Recent Development Table 152. Thermo Fisher Scientific Company Information Table 153. Thermo Fisher Scientific Business Overview Table 154. Thermo Fisher Scientific Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio Table 156. Thermo Fisher Scientific Recent Development Table 157. North America Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. North America Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 159. North America Blood & Tissue Kit Sales Market Share by Country (2021-2026) Table 160. North America Blood & Tissue Kit Sales Forecast by Country (2027-2032) & (K Units) Table 161. North America Blood & Tissue Kit Sales Market Share Forecast by Country (2027-2032) Table 162. North America Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. North America Blood & Tissue Kit Market Size by Country (2021-2026) & (US$ Million) Table 164. North America Blood & Tissue Kit Market Share by Country (2021-2026) Table 165. North America Blood & Tissue Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. North America Blood & Tissue Kit Market Share Forecast by Country (2027-2032) Table 167. Europe Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Europe Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 169. Europe Blood & Tissue Kit Sales Market Share by Country (2021-2026) Table 170. Europe Blood & Tissue Kit Sales Forecast by Country (2027-2032) & (K Units) Table 171. Europe Blood & Tissue Kit Sales Market Share Forecast by Country (2027-2032) Table 172. Europe Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Europe Blood & Tissue Kit Market Size by Country (2021-2026) & (US$ Million) Table 174. Europe Blood & Tissue Kit Market Share by Country (2021-2026) Table 175. Europe Blood & Tissue Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Europe Blood & Tissue Kit Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 179. Asia-Pacific Blood & Tissue Kit Sales Market Share by Country (2021-2026) Table 180. Asia-Pacific Blood & Tissue Kit Sales Forecast by Country (2027-2032) & (K Units) Table 181. Asia-Pacific Blood & Tissue Kit Sales Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Blood & Tissue Kit Market Size by Country (2021-2026) & (US$ Million) Table 184. Asia-Pacific Blood & Tissue Kit Market Share by Country (2021-2026) Table 185. Asia-Pacific Blood & Tissue Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Asia-Pacific Blood & Tissue Kit Market Share Forecast by Country (2027-2032) Table 187. Latin America Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Latin America Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 189. Latin America Blood & Tissue Kit Sales Market Share by Country (2021-2026) Table 190. Latin America Blood & Tissue Kit Sales Forecast by Country (2027-2032) & (K Units) Table 191. Latin America Blood & Tissue Kit Sales Market Share Forecast by Country (2027-2032) Table 192. Latin America Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Latin America Blood & Tissue Kit Market Size by Country (2021-2026) & (US$ Million) Table 194. Latin America Blood & Tissue Kit Market Share by Country (2021-2026) Table 195. Latin America Blood & Tissue Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Latin America Blood & Tissue Kit Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Blood & Tissue Kit Sales by Country (2021-2026) & (K Units) Table 199. Middle East and Africa Blood & Tissue Kit Sales Market Share by Country (2021-2026) Table 200. Middle East and Africa Blood & Tissue Kit Sales Forecast by Country (2027-2032) & (K Units) Table 201. Middle East and Africa Blood & Tissue Kit Sales Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Blood & Tissue Kit Market Size by Country (2021-2026) & (US$ Million) Table 204. Middle East and Africa Blood & Tissue Kit Market Share by Country (2021-2026) Table 205. Middle East and Africa Blood & Tissue Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Middle East and Africa Blood & Tissue Kit Market Share Forecast by Country (2027-2032) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Blood & Tissue Kit Distributors List Table 210. Blood & Tissue Kit Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Blood & Tissue Kit Image Figure 2. Global Blood & Tissue Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood & Tissue Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood & Tissue Kit Sales (2021-2032) & (K Units) Figure 5. Buffy Coat Image Figure 6. Global Buffy Coat Sales YoY Growth (2021-2032) & (K Units) Figure 7. Whole Blood Image Figure 8. Global Whole Blood Sales YoY Growth (2021-2032) & (K Units) Figure 9. Plasma or Serum Image Figure 10. Global Plasma or Serum Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Blood & Tissue Kit Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Blood & Tissue Kit Market Share by Type 2025 VS 2032 Figure 13. North America Blood & Tissue Kit Sales Market Share in Volume by Type in 2025 Figure 14. North America Blood & Tissue Kit Sales Market Share in Value by Type in 2025 Figure 15. Europe Blood & Tissue Kit Sales Market Share in Volume by Type in 2025 Figure 16. Europe Blood & Tissue Kit Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Blood & Tissue Kit Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Blood & Tissue Kit Sales Market Share in Value by Type in 2025 Figure 19. Latin America Blood & Tissue Kit Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Blood & Tissue Kit Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Blood & Tissue Kit Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Blood & Tissue Kit Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Blood & Tissue Kit Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. R&D Organisations Image Figure 26. Global R&D Organisations Sales YoY Growth (2021-2032) & (K Units) Figure 27. Biotechnology Companies Image Figure 28. Global Biotechnology Companies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Blood & Tissue Kit Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Blood & Tissue Kit Market Share by Application 2025 VS 2032 Figure 31. North America Blood & Tissue Kit Sales Market Share in Volume by Application in 2025 Figure 32. North America Blood & Tissue Kit Sales Market Share in Value by Application in 2025 Figure 33. Europe Blood & Tissue Kit Sales Market Share in Volume by Application in 2025 Figure 34. Europe Blood & Tissue Kit Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Blood & Tissue Kit Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Blood & Tissue Kit Sales Market Share in Value by Application in 2025 Figure 37. Latin America Blood & Tissue Kit Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Blood & Tissue Kit Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Blood & Tissue Kit Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Blood & Tissue Kit Sales Market Share in Value by Application in 2025 Figure 41. North America Blood & Tissue Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Blood & Tissue Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Blood & Tissue Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Blood & Tissue Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Blood & Tissue Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Blood & Tissue Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Blood & Tissue Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Blood & Tissue Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Blood & Tissue Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Blood & Tissue Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Blood & Tissue Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Blood & Tissue Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Blood & Tissue Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Blood & Tissue Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Blood & Tissue Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Blood & Tissue Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Blood & Tissue Kit Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Blood & Tissue Kit Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Buffy Coat
  • Whole Blood
  • Plasma or Serum
Applications
  • R&D Organisations
  • Biotechnology Companies
Companies covered
  • QIAGEN
  • Analytik Jena
  • Axygen (Corning)
  • Bio-Rad
  • BioVision
  • Geneaid
  • Illumina
  • Lucigen (Biosearch Technologies)
  • Macherey-Nagel
  • Norgen
  • Omega Bio-tek
  • Promega
  • Sigma-Aldrich (Merck)
  • Zymo Research
  • MGI Tech Co., Ltd.
  • Roche
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood & Tissue Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Blood & Tissue Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Blood & Tissue Kit Market by Type
  6. 1.3.1 Buffy Coat
  7. 1.3.2 Whole Blood
  8. 1.3.3 Plasma or Serum
  9. 1.4 Global Blood & Tissue Kit Market Size by Type
  10. 1.4.1 Global Blood & Tissue Kit Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Blood & Tissue Kit Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Blood & Tissue Kit Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Blood & Tissue Kit Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Blood & Tissue Kit Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Blood & Tissue Kit Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Blood & Tissue Kit Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Blood & Tissue Kit Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Blood & Tissue Kit Industry Trends
  2. 2.2 Blood & Tissue Kit Industry Drivers
  3. 2.3 Blood & Tissue Kit Industry Opportunities and Challenges
  4. 2.4 Blood & Tissue Kit Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Blood & Tissue Kit Revenue (2021-2026)
  2. 3.2 Global Top Players by Blood & Tissue Kit Sales (2021-2026)
  3. 3.3 Global Top Players by Blood & Tissue Kit Price (2021-2026)
  4. 3.4 Global Blood & Tissue Kit Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood & Tissue Kit Major Company Production Sites & Headquarters
  6. 3.6 Global Blood & Tissue Kit Company, Product Type & Application
  7. 3.7 Global Blood & Tissue Kit Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood & Tissue Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood & Tissue Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood & Tissue Kit Tier 1, Tier 2, and Tier 3
4 Blood & Tissue Kit Regional Status and Outlook
  1. 4.1 Global Blood & Tissue Kit Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Blood & Tissue Kit Historic Market Size by Region
  3. 4.2.1 Global Blood & Tissue Kit Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Blood & Tissue Kit Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Blood & Tissue Kit Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Blood & Tissue Kit Forecasted Market Size by Region
  7. 4.3.1 Global Blood & Tissue Kit Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Blood & Tissue Kit Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Blood & Tissue Kit Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Blood & Tissue Kit by Application
  1. 5.1 Blood & Tissue Kit Market by Application
  2. 5.1.1 R&D Organisations
  3. 5.1.2 Biotechnology Companies
  4. 5.2 Global Blood & Tissue Kit Market Size by Application
  5. 5.2.1 Global Blood & Tissue Kit Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Blood & Tissue Kit Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Blood & Tissue Kit Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Blood & Tissue Kit Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Blood & Tissue Kit Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Blood & Tissue Kit Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Blood & Tissue Kit Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Blood & Tissue Kit Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 QIAGEN
  2. 6.1.1 QIAGEN Company Information
  3. 6.1.2 QIAGEN Business Overview
  4. 6.1.3 QIAGEN Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 QIAGEN Blood & Tissue Kit Product Portfolio
  6. 6.1.5 QIAGEN Recent Developments
  7. 6.2 Analytik Jena
  8. 6.2.1 Analytik Jena Company Information
  9. 6.2.2 Analytik Jena Business Overview
  10. 6.2.3 Analytik Jena Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Analytik Jena Blood & Tissue Kit Product Portfolio
  12. 6.2.5 Analytik Jena Recent Developments
  13. 6.3 Axygen (Corning)
  14. 6.3.1 Axygen (Corning) Company Information
  15. 6.3.2 Axygen (Corning) Business Overview
  16. 6.3.3 Axygen (Corning) Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Axygen (Corning) Blood & Tissue Kit Product Portfolio
  18. 6.3.5 Axygen (Corning) Recent Developments
  19. 6.4 Bio-Rad
  20. 6.4.1 Bio-Rad Company Information
  21. 6.4.2 Bio-Rad Business Overview
  22. 6.4.3 Bio-Rad Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Rad Blood & Tissue Kit Product Portfolio
  24. 6.4.5 Bio-Rad Recent Developments
  25. 6.5 BioVision
  26. 6.5.1 BioVision Company Information
  27. 6.5.2 BioVision Business Overview
  28. 6.5.3 BioVision Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BioVision Blood & Tissue Kit Product Portfolio
  30. 6.5.5 BioVision Recent Developments
  31. 6.6 Geneaid
  32. 6.6.1 Geneaid Company Information
  33. 6.6.2 Geneaid Business Overview
  34. 6.6.3 Geneaid Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Geneaid Blood & Tissue Kit Product Portfolio
  36. 6.6.5 Geneaid Recent Developments
  37. 6.7 Illumina
  38. 6.7.1 Illumina Company Information
  39. 6.7.2 Illumina Business Overview
  40. 6.7.3 Illumina Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Illumina Blood & Tissue Kit Product Portfolio
  42. 6.7.5 Illumina Recent Developments
  43. 6.8 Lucigen (Biosearch Technologies)
  44. 6.8.1 Lucigen (Biosearch Technologies) Company Information
  45. 6.8.2 Lucigen (Biosearch Technologies) Business Overview
  46. 6.8.3 Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio
  48. 6.8.5 Lucigen (Biosearch Technologies) Recent Developments
  49. 6.9 Macherey-Nagel
  50. 6.9.1 Macherey-Nagel Company Information
  51. 6.9.2 Macherey-Nagel Business Overview
  52. 6.9.3 Macherey-Nagel Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Macherey-Nagel Blood & Tissue Kit Product Portfolio
  54. 6.9.5 Macherey-Nagel Recent Developments
  55. 6.10 Norgen
  56. 6.10.1 Norgen Company Information
  57. 6.10.2 Norgen Business Overview
  58. 6.10.3 Norgen Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Norgen Blood & Tissue Kit Product Portfolio
  60. 6.10.5 Norgen Recent Developments
  61. 6.11 Omega Bio-tek
  62. 6.11.1 Omega Bio-tek Company Information
  63. 6.11.2 Omega Bio-tek Business Overview
  64. 6.11.3 Omega Bio-tek Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Omega Bio-tek Blood & Tissue Kit Product Portfolio
  66. 6.11.5 Omega Bio-tek Recent Developments
  67. 6.12 Promega
  68. 6.12.1 Promega Company Information
  69. 6.12.2 Promega Business Overview
  70. 6.12.3 Promega Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Promega Blood & Tissue Kit Product Portfolio
  72. 6.12.5 Promega Recent Developments
  73. 6.13 Sigma-Aldrich (Merck)
  74. 6.13.1 Sigma-Aldrich (Merck) Company Information
  75. 6.13.2 Sigma-Aldrich (Merck) Business Overview
  76. 6.13.3 Sigma-Aldrich (Merck) Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio
  78. 6.13.5 Sigma-Aldrich (Merck) Recent Developments
  79. 6.14 Zymo Research
  80. 6.14.1 Zymo Research Company Information
  81. 6.14.2 Zymo Research Business Overview
  82. 6.14.3 Zymo Research Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Zymo Research Blood & Tissue Kit Product Portfolio
  84. 6.14.5 Zymo Research Recent Developments
  85. 6.15 MGI Tech Co., Ltd.
  86. 6.15.1 MGI Tech Co., Ltd. Company Information
  87. 6.15.2 MGI Tech Co., Ltd. Business Overview
  88. 6.15.3 MGI Tech Co., Ltd. Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio
  90. 6.15.5 MGI Tech Co., Ltd. Recent Developments
  91. 6.16 Roche
  92. 6.16.1 Roche Company Information
  93. 6.16.2 Roche Business Overview
  94. 6.16.3 Roche Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Roche Blood & Tissue Kit Product Portfolio
  96. 6.16.5 Roche Recent Developments
  97. 6.17 Thermo Fisher Scientific
  98. 6.17.1 Thermo Fisher Scientific Company Information
  99. 6.17.2 Thermo Fisher Scientific Business Overview
  100. 6.17.3 Thermo Fisher Scientific Blood & Tissue Kit Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio
  102. 6.17.5 Thermo Fisher Scientific Recent Developments
7 North America by Country
  1. 7.1 North America Blood & Tissue Kit Sales by Country
  2. 7.1.1 North America Blood & Tissue Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Blood & Tissue Kit Sales by Country (2021-2026)
  4. 7.1.3 North America Blood & Tissue Kit Sales Forecast by Country (2027-2032)
  5. 7.2 North America Blood & Tissue Kit Market Size by Country
  6. 7.2.1 North America Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Blood & Tissue Kit Market Size by Country (2021-2026)
  8. 7.2.3 North America Blood & Tissue Kit Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Blood & Tissue Kit Sales by Country
  2. 8.1.1 Europe Blood & Tissue Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Blood & Tissue Kit Sales by Country (2021-2026)
  4. 8.1.3 Europe Blood & Tissue Kit Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Blood & Tissue Kit Market Size by Country
  6. 8.2.1 Europe Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Blood & Tissue Kit Market Size by Country (2021-2026)
  8. 8.2.3 Europe Blood & Tissue Kit Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Blood & Tissue Kit Sales by Country
  2. 9.1.1 Asia-Pacific Blood & Tissue Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Blood & Tissue Kit Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Blood & Tissue Kit Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Blood & Tissue Kit Market Size by Country
  6. 9.2.1 Asia-Pacific Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Blood & Tissue Kit Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Blood & Tissue Kit Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Blood & Tissue Kit Sales by Country
  2. 10.1.1 South America Blood & Tissue Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Blood & Tissue Kit Sales by Country (2021-2026)
  4. 10.1.3 South America Blood & Tissue Kit Sales Forecast by Country (2027-2032)
  5. 10.2 South America Blood & Tissue Kit Market Size by Country
  6. 10.2.1 South America Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Blood & Tissue Kit Market Size by Country (2021-2026)
  8. 10.2.3 South America Blood & Tissue Kit Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Blood & Tissue Kit Sales by Country
  2. 11.1.1 Middle East and Africa Blood & Tissue Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Blood & Tissue Kit Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Blood & Tissue Kit Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Blood & Tissue Kit Market Size by Country
  6. 11.2.1 Middle East and Africa Blood & Tissue Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Blood & Tissue Kit Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Blood & Tissue Kit Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Blood & Tissue Kit Value Chain Analysis
  2. 12.1.1 Blood & Tissue Kit Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Blood & Tissue Kit Production Mode & Process
  7. 12.2 Blood & Tissue Kit Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Blood & Tissue Kit Distributors
  10. 12.2.3 Blood & Tissue Kit Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst